Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir.

× No keyword cloud information.

13 in total

Review 1. Pharmacogenomics of CYP3A: considerations for HIV treatment.

Authors: Sukhwinder S Lakhman; Qing Ma; Gene D Morse
Journal: Pharmacogenomics Date: 2009-08 Impact factor: 2.533

Review 2. A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.

Authors: R Douglas Bruce; David E Moody; Frederick L Altice; Marc N Gourevitch; Gerald H Friedland
Journal: Expert Rev Clin Pharmacol Date: 2013-05 Impact factor: 5.045

3. P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception.

Authors: Sarah M Brown; Scott D Campbell; Amanda Crafford; Karen J Regina; Michael J Holtzman; Evan D Kharasch
Journal: J Pharmacol Exp Ther Date: 2012-06-27 Impact factor: 4.030

Review 4. Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals.

Authors: Dhananjay Pal; Deep Kwatra; Mukul Minocha; Durga K Paturi; Balasubrahmanyam Budda; Ashim K Mitra
Journal: Life Sci Date: 2010-11-01 Impact factor: 5.037

Review 5. Methadone, buprenorphine, and street drug interactions with antiretroviral medications.

Authors: Valerie A Gruber; Elinore F McCance-Katz
Journal: Curr HIV/AIDS Rep Date: 2010-08 Impact factor: 5.071

Review 6. Management of common psychiatric conditions in the HIV-positive population.

Authors: Kelly Brogan; Joseph Lux
Journal: Curr HIV/AIDS Rep Date: 2009-05 Impact factor: 5.071

7. Interaction between buprenorphine and atazanavir or atazanavir/ritonavir.

Authors: Elinore F McCance-Katz; David E Moody; Gene D Morse; Qing Ma; Robin DiFrancesco; Gerald Friedland; Patricia Pade; Petrie M Rainey
Journal: Drug Alcohol Depend Date: 2007-07-23 Impact factor: 4.492

Review 8. Pharmacokinetic and pharmacodynamic considerations in developing a response to the opioid epidemic.

Authors: Rajiv Balyan; David Hahn; Henry Huang; Vidya Chidambaran
Journal: Expert Opin Drug Metab Toxicol Date: 2020-02-24 Impact factor: 4.481

9. Use of an Acetyl Derivative to Improve GC-MS Determination of Norbuprenorphine in the Presence of High Concentrations of Buprenorphine in Urine.

Authors: Joel R Gervais; Gregory A Hobbs
Journal: J Anal Toxicol Date: 2016-01-25 Impact factor: 3.367

10. Clinical care of the HIV-infected drug user.

Authors: R Douglas Bruce; Frederick L Altice
Journal: Infect Dis Clin North Am Date: 2007-03 Impact factor: 5.982